Johnson & Johnson price target raised to $162 from $156 at Guggenheim
The Fly

Johnson & Johnson price target raised to $162 from $156 at Guggenheim

Guggenheim raised the firm’s price target on Johnson & Johnson to $162 from $156 and keeps a Neutral rating on the shares. The firm is updating its J&J model following Q3 results, driven by the company’s results and updated FY24 guidance, noting that its raised target is mainly driven by modest increases in sales estimates for several products in the Innovative Medicines segment, partially offset by modestly reduced sales estimates in MedTech.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App